Abbott Laboratories
XHAM:ABL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abbott Laboratories
XHAM:ABL
|
US |
|
R
|
Ryder System Inc
F:RYD
|
US |
|
S
|
Shaw Communications Inc
F:SWC
|
CA |
|
O
|
Onto Innovation Inc
XMUN:NNM
|
US |
|
C
|
CITIC Securities Co Ltd
OTC:CIIHF
|
CN |
|
I
|
Imperial Brands PLC
OTC:IMBBY
|
UK |
|
J
|
JCDecaux SE
XMUN:DCS
|
FR |
Wall St Price Targets
ABL Price Targets Summary
Abbott Laboratories
According to Wall Street analysts, the average 1-year price target for ABL is 102.21 EUR with a low forecast of 77.82 EUR and a high forecast of 125.74 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABL's stock price target?
Price Target
102.21
EUR
According to Wall Street analysts, the average 1-year price target for ABL is 102.21 EUR with a low forecast of 77.82 EUR and a high forecast of 125.74 EUR.
What is the Revenue forecast for Abbott Laboratories?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 7 years is 9%.
What is the Operating Income forecast for Abbott Laboratories?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 7 years is 14%.
What is the Net Income forecast for Abbott Laboratories?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 7 years is 15%.
